FDA Approvals - FDA panel rejects Avastin for breast cancer treatmentWASHINGTON - A
FDA panel rejects Avastin for breast cancer treatment
WASHINGTON - A Food and Drug Administration panel took a major step Wednesday toward ending use of the best-selling drug Avastin for treating advanced breast cancer in the United States, despite appeals from distraught patients and the company manufacturing the drug.